BioSpace News Archive

Thiocyanate, which is responsible for the systemic activity behind the mustard plant’s natural herbicidal (weed-killer) properties, is the third molecule from mustard seed that MustGrow has isolated, extracted, and concentrated.

At the beginning of an immune response, a molecule known to mobilize immune cells into the bloodstream, where they home in on infection sites, rapidly shifts position, a new study shows

The acquisition brings behavioral science, AI, and virtual care enhancements to the BioIQ digital health testing platform.

Grant Will Provide Bridge Funding for Dr. H Lee Sweeney’s Research to Understand and Improve Gene Therapy in Duchenne

Multiple Human Clinical Trials Have Demonstrated Unprecedented Success in Cancers, Including HCC Liver Cancer, Vascular and Other Diseases, and Viruses

PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform designed to provide more effective and safer products, today announced the pricing of an underwritten public offering of 7,875,000 shares of its common stock,

Indegene, a global enterprise healthtech solutions company and ConTIPI Medical Ltd, an innovator in the field of providing non-surgical and disposable solutions for women with various pelvic floor disfunctions, today announced a partnership to bring a new device to the market to help women suffering from Pelvic Organ Prolapse (POP).

Wellmarker Bio(www.wmbio.co) announced that on February 23, 2021 the company received approval from the Australian Therapeutic Goods Administration (TGA) for a Phase I clinical trial using WM-S1-030, a targeted anti-cancer drug for colorectal cancer and progressive cancer.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the company has formed a community of periodontists through the development of the Waterlase Perio Academy (WPA)

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today the approval to market our dietary supplements on the RangeMe B2B platform.